August 30, 2015 /
An MS Patients Story
By Amy Lucille,
My dearest Ant Man,
I am so sorry you have to watch me cry. I am so sorry that I cannot get down on the floor and play with you for days at a time, sometimes weeks. I am so sorry that you have to deal with the issues that come with my multiple sclerosis for your entire life.
I know you don’t understand why I can’t run or walk very fast to do anything, let alone play with you. I know you don’t understand why I can’t get up after I lay down for a while. I know you don’t understand why I have to go to bed when it’s still daytime, sometimes. I can’t imagine how difficult that can be for you… and it hurts me to know that this won’t get any better.
All I want for you is to have a full and happy childhood. It’s not fair for you to have to be stuck in the house on beautiful weekends because your mommy can’t get out of bed. It’s not fair that we couldn’t go to the park tonight, after you were so wonderful and helpful all day, because my muscle spasms aren’t letting me move farther than from the floor to the bed.
I know that you want to cuddle, but it hurts so bad to hold you. I want nothing more than to pick you up and swing you around and hug and kiss you a hundred times, but I can’t even lean over to hug you. I am so sorry that I can’t reach the car that rolled under the couch, and I know it was your favorite car. I’m sorry you have to eat easy microwavable meals until I recover from these spasms. I am sorry I can’t take care of you the way I should.
I know that the spasms will only last a few days, and the recovery only a couple or a few weeks after, but I also know they will happen again and again. I know that this is not the first or the last of a long line of symptoms you will have to deal with for the rest of my life. For that, I am sorry.
I know you don’t understand why these things are happening, and you deserve so much better. I am sorry I can’t be all the mommy that I want to be to you. I’m sorry that I can’t sit and help you put together your CONTINUE READING
PLEASE CLICK to Return here to LEAVE COMMENTS
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here
.========================================================
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- People Wait an Average of 50 Days to See a Neurologist, and People with MS Wait Even Longer: What Can We Do to Improve Access to MS Care?
- Key Findings on GLP-1 Use in MS
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
- This Blood Test Tracks MS Activity? (Octave Explained)
- Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
- Will Medicare Pay for a Mobility Scooter?
- Vagus nerve stimulation (VNS)
- Vitamin D Deficiency in Adults: Symptoms, Treatments, and Related Health Conditions
- How to Get Through an MRI if You’re Claustrophobic
- How MS Can Affect Your Oral Health
- Signs of multiple sclerosis show up in blood years before symptoms, study finds
- MS patients less likely to have Alzheimer’s, study finds
- APOE4 gene variant linked to greater nerve damage in MS: Study
- High Epstein-Barr antibody levels over time may aid MS diagnosis
- Stopping Ocrevus in stable MS doesn’t seem to raise 2-year risk, study finds
- Online Survey: Stress and MS – from the National MS Society
- High-Altitude Gene Helps Heal Myelin Damage
- Talking Biosimilars – Unlocking Patient access through coordinated action
- Beyond One Drug: What the Tolebrutinib Decision Teaches Us About Progressive MS Trials.
